Evidence supporting the use of: Vitamin K mixed)
For the health condition: Bleeding (internal)
Synopsis
Source of validity: Scientific
Rating (out of 5): 5
Vitamin K is well-established in modern medicine as an essential factor in the synthesis of clotting factors II, VII, IX, and X in the liver. Its use in treating bleeding, especially internal bleeding due to vitamin K deficiency or overdose of anticoagulant medications such as warfarin, is supported by robust scientific evidence. Vitamin K1 (phytonadione) is frequently administered intravenously or orally to rapidly correct coagulopathy and control bleeding. This intervention is standard in cases of internal bleeding caused by hypoprothrombinemia, liver disease, or anticoagulant toxicity. Numerous clinical trials, observational studies, and consensus guidelines have documented its safety and efficacy. Vitamin K is listed on the World Health Organization's List of Essential Medicines for this purpose. Its role is not only limited to treating acute bleeding events but also in prophylactic settings, such as the prevention of hemorrhagic disease of the newborn. In summary, the use of vitamin K for supporting or treating internal bleeding is solidly grounded in modern scientific understanding and clinical practice, making it a well-validated medical intervention.
Other health conditions supported by Vitamin K mixed)
Bleeding (external)Bleeding (internal)
Blood Clots (prevention of)
Broken Bones
Bruises (healing)
Bruises (prevention)
Calcium Deficiency
Cardiovascular Disease
Cirrhosis of the Liver
Osteoporosis